Cargando…

A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus

Allogeneic mesenchymal stem/stromal cells (MSCs) have been widely studied as an alternative cell source for regenerative medicine. Here, we report a long-term follow-up study of allogeneic bone marrow and/or umbilical cord MSC transplantation (MSCT) in severe and drug-refractory systemic lupus eryth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dandan, Zhang, Huayong, Liang, Jun, Wang, Hong, Hua, Bingzhu, Feng, Xuebing, Gilkeson, Gary S., Farge, Dominique, Shi, Songtao, Sun, Lingyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918528/ https://www.ncbi.nlm.nih.gov/pubmed/29478901 http://dx.doi.org/10.1016/j.stemcr.2018.01.029

Ejemplares similares

Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2012)

Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis
por: Zhang, Huayong, et al.
Publicado: (2017)

Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells
por: Wen, Lihui, et al.
Publicado: (2019)

Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study
por: Liang, Jun, et al.
Publicado: (2018)

Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus
por: Feng, Xuebing, et al.
Publicado: (2010)

Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus
por: Cao, Zhouli, et al.
Publicado: (2023)

Inhibition of Aberrant Circulating Tfh Cell Proportions by Corticosteroids in Patients with Systemic Lupus Erythematosus
por: Feng, Xuebing, et al.
Publicado: (2012)

A CD8 T Cell/Indoleamine 2,3-Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2014)

Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus
por: Tang, Yu, et al.
Publicado: (2012)

Serum IFN‐γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients
por: Wang, Dandan, et al.
Publicado: (2017)

Characteristics of Hearing Loss in Patients with Systemic Lupus Erythematosus
por: Chen, Huixian, et al.
Publicado: (2022)

Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus
por: Tani, Chiara, et al.
Publicado: (2017)

Association Between Mycophenolate Mofetil Use and Subsequent Infections Among Hospitalized Patients with Systemic Lupus Erythematosus: A Nested Case–Control Study
por: Guo, Qingqing, et al.
Publicado: (2023)

Development of Clinical Decision Models for the Prediction of Systemic Lupus Erythematosus and Sjogren’s Syndrome Overlap
por: Han, Yan, et al.
Publicado: (2023)

Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study
por: Wang, Dandan, et al.
Publicado: (2014)

Association of TNF-α with Impaired Migration Capacity of Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2014)

Umbilical Cord-Derived Mesenchymal Stem Cells Suppress Autophagy of T Cells in Patients with Systemic Lupus Erythematosus via Transfer of Mitochondria
por: Chen, Jinyun, et al.
Publicado: (2016)

Comprehensive expression profile of long non-coding RNAs in Peripheral blood mononuclear cells from patients with neuropsychiatric systemic lupus erythematosus
por: Geng, Linyu, et al.
Publicado: (2020)

Update on mesenchymal stem cell-based therapy in lupus and scleroderma
por: Cras, Audrey, et al.
Publicado: (2015)

Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2020)

Elevated Apoptosis and Impaired Proliferation Contribute to Downregulated Peripheral γ δ T Cells in Patients with Systemic Lupus Erythematosus
por: Lu, Zhimin, et al.
Publicado: (2013)

Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus
por: Zhu, Yantong, et al.
Publicado: (2018)

Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs
por: Yao, Genhong, et al.
Publicado: (2022)

Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE)
por: Jiang, Wei, et al.
Publicado: (2014)

Comparative proteomics analysis of plasma protein in patients with neuropsychiatric systemic lupus erythematosus
por: Chen, Chen, et al.
Publicado: (2020)

Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis
por: Liang, Jun, et al.
Publicado: (2015)

Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis
por: Liu, Rui, et al.
Publicado: (2015)

Pregnancy outcomes among African–American patients with systemic lupus erythematosus compared with controls
por: Barnado, April, et al.
Publicado: (2014)

Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2022)

Correction to: Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus
Publicado: (2023)

Smoking and secondhand smoke among patients with systemic lupus erythematosus and controls: associations with disease and disease damage
por: Minkin, Samantha J, et al.
Publicado: (2014)

Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients
por: Yuan, Xinran, et al.
Publicado: (2019)

Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus
por: Huang, Saisai, et al.
Publicado: (2023)

Intramuscular Transplantation of Allogeneic Mesenchymal Stromal Cells Derived from Equine Umbilical Cord
por: Dias, Marianne Camargos, et al.
Publicado: (2016)

The Nephroprotective Effects of the Allogeneic Transplantation with Mesenchymal Stromal Cells Were Potentiated by ω3 Stimulating Up-Regulation of the PPAR-γ
por: de Oliveira, Andreia Silva, et al.
Publicado: (2023)

Umbilical Cord-Derived Mesenchymal Stem Cells Inhibit Cadherin-11 Expression by Fibroblast-Like Synoviocytes in Rheumatoid Arthritis
por: Zhao, Cheng, et al.
Publicado: (2015)

The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus
por: Ben-Zvi, Ilan, et al.
Publicado: (2010)

Immune response to allogeneic equine mesenchymal stromal cells
por: Kamm, J. Lacy, et al.
Publicado: (2021)

Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study
por: Wen, Lihui, et al.
Publicado: (2022)

Predictors of improvement in disease activity in first hospitalized patients with systemic lupus erythematosus: a multicenter retrospective study of a Chinese cohort
por: Li, Mei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mjbqq5d6k0jonna2qldrhrrluu